What is the lowest sales figure reported for the Top 25% of Learningrx centers?
Learningrx Franchise · 2025 FDDAnswer from 2025 FDD Document
| Sample: | Top 25% | Mid-Top | Mid-Lower | Bottom | |
|---|---|---|---|---|---|
| 25% | 25% | 25% | |||
| # of Centers: | 11 | 10 | 10 | 10 | 4 |
| Top Sales | $893,375 | $486,808 | $287,188 | $167,835 | $376,730 |
| Low Sales | $507,737 | $300,712 | $172,105 | $35,673 | $133,094 |
| Median Sales | $601,971 | $391,046 | $229,711 | $75,215 | $195,526 |
| Average Sales | $631,577 | $402,343 | $229,935 | $85,218 | $225,219 |
| Centers meeting or | 2 / 18% | 5 / 50% | 5 / 50% | 3 / 30% | 1 / 25% |
| exceeding average: | |||||
| Median Monthly Local | $3,559 | $3,107 | $2,032 | $879 | $1,779 |
| Marketing Expense |
Source: Item 19 — FINANCIAL PERFORMANCE REPRESENTATIONS (FDD pages 46–48)
What This Means (2025 FDD)
According to Learningrx's 2025 Franchise Disclosure Document, the lowest sales figure for the top 25% of Learningrx centers is $507,737. This data is based on the gross revenue records from franchisees for the fiscal year ending September 30, 2024. The financial performance representation includes historical gross revenue information of centers operating in the United States.
This figure represents the lowest revenue achieved by a center within the top quartile of performers, providing a benchmark for potential franchisees who aim to be among the highest-earning Learningrx locations. It's important to note that this is not a guarantee of future performance, as individual results may vary. The FDD explicitly states that there is no assurance that a new franchisee will earn as much.
The financial data is derived from 45 franchised outlets that had complete data and were open for the full 12 months during the specified fiscal year. These centers were divided into quartiles based on their total revenues. The top quartile, representing the top 25%, consisted of 11 centers with the highest total revenue. Prospective franchisees should consider this information as a general indicator of potential revenue, while recognizing that factors such as location, market conditions, and management skills can significantly impact actual performance.
Learningrx also emphasizes that written substantiation for the financial performance representation will be made available to prospective franchisees upon reasonable request. This allows potential franchisees to further scrutinize the data and understand the basis for these financial performance representations. Furthermore, the FDD advises reporting any unauthorized financial performance information received to Learningrx management, the Federal Trade Commission, and appropriate state regulatory agencies, ensuring transparency and compliance.